- Home
- PGNY vs CERT Comparison
PGNY vs CERT Comparison
Compare PGNY & CERT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PGNY
- CERT
- Stock Information
- Founded
- PGNY 2008
- CERT 2008
- Country
- PGNY United States
- CERT United States
- Employees
- PGNY N/A
- CERT N/A
- Industry
- PGNY Misc Health and Biotechnology Services
- CERT Retail: Computer Software & Peripheral Equipment
- Sector
- PGNY Health Care
- CERT Technology
- Exchange
- PGNY Nasdaq
- CERT Nasdaq
- Market Cap
- PGNY 1.8B
- CERT 1.9B
- IPO Year
- PGNY 2019
- CERT 2020
- Fundamental
- Price
- PGNY $20.98
- CERT $10.54
- Analyst Decision
- PGNY Buy
- CERT Buy
- Analyst Count
- PGNY 8
- CERT 6
- Target Price
- PGNY $22.43
- CERT $15.60
- AVG Volume (30 Days)
- PGNY 880.6K
- CERT 1.7M
- Earning Date
- PGNY 08-05-2025
- CERT 08-05-2025
- Dividend Yield
- PGNY N/A
- CERT N/A
- EPS Growth
- PGNY N/A
- CERT N/A
- EPS
- PGNY 0.57
- CERT N/A
- Revenue
- PGNY $1,213,181,000.00
- CERT $394,498,000.00
- Revenue This Year
- PGNY $7.01
- CERT $11.57
- Revenue Next Year
- PGNY $11.53
- CERT $8.93
- P/E Ratio
- PGNY $36.61
- CERT N/A
- Revenue Growth
- PGNY 9.46
- CERT 9.37
- 52 Week Low
- PGNY $13.39
- CERT $8.64
- 52 Week High
- PGNY $30.42
- CERT $16.93
- Technical
- Relative Strength Index (RSI)
- PGNY 43.42
- CERT 35.72
- Support Level
- PGNY $20.70
- CERT $10.41
- Resistance Level
- PGNY $22.16
- CERT $12.41
- Average True Range (ATR)
- PGNY 0.73
- CERT 0.52
- MACD
- PGNY -0.01
- CERT -0.10
- Stochastic Oscillator
- PGNY 12.56
- CERT 7.20
About PGNY Progyny Inc.
Progyny Inc is a benefits management company specializing in fertility, family building, and women's health benefits solutions. Its clients include employers across various industries. The fertility benefits solution consists of treatment services (Smart Cycles), access to the Progyny network of high-quality fertility specialists that perform the Smart Cycle treatments, and active management of the selective network of high-quality provider clinics.
About CERT Certara Inc.
Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval and increase patient access to medicines. The company has its business presence in the Americas which is also it key revenue generating market, EMEA and Asia Pacific region.